Error correction enables use of Oxford Nanopore technology for reference-free transcriptome analysis | Nature Communications
New research algorithms yield accuracy gains for nanopore sequencing
Oxford Nanopore at ASHG 2022: One sequencing platform for all your biology
Oxford Nanopore Technologies Raises $180 Million to Expand Development of Its Revolutionary Hand-held DNA Sequencer; Might Medical Labs Get a POCT Solution? - Dark Daily
Oxford Nanopore announces groundbreaking GridION and MinION gene sequencers
A big City win for life sciences as firm involved in COVID-19 fight surges on market debut | Business News | Sky News
Oxford Nanopore Technologies wins CE-IVD mark for Covid-19 test
Oxford Nanopore announces multiple releases, for high-accuracy, content-rich, high-throughput whole-genome sequencing, and dynamic targeted sequencing
News
Oxford Nanopore scores higher revenues and smaller losses in 2022
Oxford Nanopore Technology Update Shows Consolidations and Updates for a Single, High-performance Sequencing Platform | Business Wire
Tecan and Oxford Nanopore build new alliance
Oxford Nanopore mulls HQ move to Abingdon Business Park | EG News
Updated: Companies settle gene technology patent fight that was shrouded in mystery | Science | AAAS
NIHR, Oxford Nanopore announce new health study - TOSP
Oxford Nanopore and Circulomics launch kits to enable routine sequencing of ultra-long fragments of DNA - Scientific Technology News
Emirates News Agency - UAE's Group 42 and UK's Oxford Nanopore co-develop ultra-scalable solution for COVID-19 detection
Tecan and Oxford Nanopore build alliance
.jpg "Nanopore technology allows point-of-care SARS-CoV-2 genomic sequencing")
Nanopore technology allows point-of-care SARS-CoV-2 genomic sequencing
Oxford Nanopore Technologies and Cyclomics begin developer testing on non-invasive method for accurate and fast detection of molecules associated with cancer
News - Future Genomics Technologies
Oxford Nanopore - News, Articles etc. - European Pharmaceutical Review
Oxford Nanopore on Twitter: "Today @nanopore & 4bases announce a new collaboration to enable a decentralised, flexible & scalable method to identify #cancer driver genes & significantly decrease turnaround time for clinical
